Recent

% | $
Quotes you view appear here for quick access.

Antares Pharma Inc. Message Board

h55h 15 posts  |  Last Activity: Jul 1, 2015 4:30 PM Member since: Dec 22, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    One of a few

    by cwajga1 Jul 1, 2015 1:27 PM

    Yesterday was longs calling sick day! Let's hope for better days ahead.. ATRS is really testing our patience.

    Long,

    Sentiment: Strong Buy

  • h55h h55h Jun 24, 2015 10:46 AM Flag

    Great News!!! The best is yet to come. Double digits next year baby!

    Go ATRS!!!
    Long,

    Sentiment: Strong Buy

  • Reply to

    Bears

    by khan.shawn Jun 18, 2015 10:26 AM
    h55h h55h Jun 18, 2015 1:46 PM Flag

    Let them do whatever they want to do. The best is yet to come for the longs.

    GO ATRS!!!
    Long,

    Sentiment: Strong Buy

  • Reply to

    Buy and Hold Logic

    by pinedridge Jun 12, 2015 6:13 PM
    h55h h55h Jun 12, 2015 6:53 PM Flag

    Let them do whatever they want to do. The best is yet to come for the longs. Once it starts there's no looking back so those with shares will be very happy they did not sell ATRS for short term gain. I'm holding for another two years which I believe will see us trade in double digits for certain. GREAT POST!

    GO ATRS!!!
    Long,

    Sentiment: Strong Buy

  • Reply to

    looks like our shares want to go up in price

    by tappyt_2014 Jun 10, 2015 10:18 AM
    h55h h55h Jun 10, 2015 12:08 PM Flag

    It's going to be a good day for us! ATRS needs to catch up so don't be surprise to see one to two hundred percent increase this year. Shorts had their glory and now it's our time. We all know many good things are coming so Antares is a perfect stock to buy and hold for few years or more. GREAT INVESTMENT AT $2+

    GO ATRS!!!
    Long,

    Sentiment: Strong Buy

  • Reply to

    Sumatriptan

    by saltyboy21 Jun 8, 2015 10:51 PM

    Antares is expecting Sumatriptan approval any day.
    Teva is our distribution partner.
    Profit split 50/50
    Launch product by late this year or early next year.

    GO ATRS!!!
    Long,

    Sentiment: Strong Buy

  • Reply to

    What's wrong with ATRS?

    by bindroy Jun 6, 2015 9:05 AM

    Don't listen to the shorts or traders and miss out. We can trade at $10+ as well.. buy or hold ATRS like you're buying it for the first time. Soon you won't be able to buy any shares under $5. Things will change very quickly and the longs will finally be happy owing the stock. What is about to happen to a little company is what we're all been waiting for. ATRS is one of the best biotech companies to buy right now and hold one to two years.

    GO ATRS!!!
    Long,

    Sentiment: Strong Buy

  • Reply to

    $200k Otrexup Peak Revs. When?

    by pinedridge Jun 6, 2015 8:06 AM

    You had me worried there for a moment. I thought you meant to say $200 dollars. Best time to buy and hold for a year or two.

    Go ATRS!!!
    Long,

    Sentiment: Strong Buy

  • Reply to

    Bull and Bear 2,20 ???

    by nammuang Jun 5, 2015 11:16 AM
    h55h h55h Jun 5, 2015 12:31 PM Flag

    I like your post!

    History in the making right here.. How soon will we see ATRS trading in double digits is the question.

    GO ATRS!!!
    Long,

    Sentiment: Strong Buy

  • It is now available on the website.. Double digits sooner than you think! Don't sell to soon. Let's go ATRS!!

    Antares Pharma to Present at the Jefferies 2015 Global Healthcare Conference June 4 at 12:30 p.m. (EDT)
    Access URL: http://wsw.com/webcast/jeff88/atrs

    Long,

    Sentiment: Strong Buy

  • h55h h55h May 12, 2015 2:46 PM Flag

    Recent Developments and First Quarter 2015 Highlights
    • Priced a firm commitment underwritten public offering of 23,000,000 shares of the Company's common stock, which includes 3,000,000 shares pursuant to the underwriters' exercise of their option in full, at a purchase price to the public of $2.00 per share, resulting in net proceeds to the Company of $43.2 million (before estimated offering expenses payable by the Company). The offering is expected to close on or about May 11, 2015, subject to customary closing conditions.

    • Increased the number of prescriptions to 6,722 and unique prescribers of OTREXUP(TM) (methotrexate) injection to approximately 1,546 physicians at the end of the first quarter of 2015 as compared to 496 prescriptions and approximately 173 physicians at the end of the first quarter of 2014, according to Symphony Health Solutions.

    • Reported positive top-line pharmacokinetic results that showed that the primary endpoint was achieved in the Company's ongoing, multi-center, phase 3 clinical study (QST-13-003) evaluating the efficacy and safety of testosterone enanthate administered once-weekly by subcutaneous injection using the QuickShot(R) auto injector in testosterone deficient adult males. The Company also received written recommendations from the U.S. Food and Drug Administration (FDA) related to its clinical development program for QuickShot(R) Testosterone (testosterone enanthate) injection (QS T). Based on the number of subjects in previous studies and in the current phase 3 study, the Company anticipates that it may need approximately 70 additional subjects exposed to QS T for six months.

    • Received notification from Ferring Pharmaceuticals Inc. (Ferring) of the approval of ZOMACTON(TM) (somatropin [rDNA origin]) for injection, and the 10 mg needle-free delivery system ZOMA-Jet(TM). Ferring purchased the U.S. rights to ZOMACTON(TM), formerly TEV-TROPIN(R), and ZOMA-Jet(TM), formerly Tjet(R), in December 2014 from Teva Pharmaceutical Industries, Ltd. Ferring developed and has marketed ZOMACTON(TM) outside of the U.S. since 1988 and in 47 countries globally.

    • Announced the settlement of all litigation between Antares and Medac Pharma, Inc. and its parent, medac GmbH. The settlement agreement provides for a royalty-free cross-license under the patents-in-suit and their families allowing the manufacture and sale of OTREXUP(TM) and Rasuvo(TM) in and for the U.S.

    • Announced that the FDA had issued a complete response letter regarding the Company's Abbreviated New Drug Application (ANDA) for VIBEX(R) Sumatriptan Injection USP for the acute treatment of migraine, providing revisions to labelling and citing minor deficiencies.

    • Regained U.S. marketing rights to OTREXUP(TM) (methotrexate) injection for subcutaneous use for the psoriasis indication through the termination of an exclusive promotion and marketing agreement with LEO Pharma A/S, effective June 23, 2015.

    "In addition to solid financial performance in the first quarter, we are pleased that our public offering demonstrated renewed commitment from existing shareholders and enabled us to expand our shareholder base with several high-quality investors," said Eamonn P. Hobbs, President and Chief Executive Officer of the Company. "We intend to continue to focus on the commercialization of OTREXUP and on our pipeline programs and device technology in order to remain opportunistic in the growing drug/device combination product marketplace."

    Sentiment: Strong Buy

  • Shorts have nothing and will finally move on.

    GO ATRS
    LONG,

    Sentiment: Strong Buy

  • Reply to

    scripts

    by bindroy May 9, 2015 11:09 AM

    This is my long term stock and I truly believe we have turned the corner. I've never felt better owning ATRS than I do today. The train is about to accelerate in this time in the right direction. The big boys understand what's going on and now we're playing a totally different game. I don't have inside information just a real good feeling that have not had for a while owning ATRS.

    Long,
    GO ATRS

    Sentiment: Strong Buy

  • Reply to

    scripts

    by bindroy May 9, 2015 11:09 AM
    h55h h55h May 9, 2015 12:47 PM Flag

    I agree.. Now that the fear of a secondary is removed for now we should be able to bounce back over $3 quickly and hold until the next good news is announced. Is it possible to go any lower? You make that call. I would not wait to long to purchase as this is a quick stop for the big boys to get on. The door will close and the train will start moving in the right direction so take advantage of it while you can. I've been a shareholder for few years just purchased more shares and never sold. I'm very excited moving forward.

    Long,
    GO ATRS

    Sentiment: Strong Buy

  • Reply to

    oversold

    by dsr5152 Apr 24, 2015 7:53 PM
    h55h h55h Apr 25, 2015 2:37 PM Flag

    Don't worry.. this year or early next year will see double digits.

    Long
    GO ATRS!!!

    Sentiment: Strong Buy

ATRS
2.12-0.01(-0.47%)Jul 6 4:00 PMEDT